Topic · Renal and Vascular Pathologies
Most cited papers in Renal and Vascular Pathologies
What are the most cited papers in Renal and Vascular Pathologies?
The most cited paper in Renal and Vascular Pathologies is "Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes" (Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al., 2001), with 6,043 citations. Next come "Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)" (3,992) and "Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis" (3,625).
Showing 50 of 100 papers. Every paper with more than 606 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine | 20 Sep 2001 | 6,043 |
| 2 | Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Andrew S. Levey, Kai‐Uwe Eckardt, Yusuke Tsukamoto et al. · Kidney International | 6 May 2005 | 3,992 |
| 3 | Benefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis Henry J.M. Barnett, D. Wayne Taylor, Michael Eliasziw et al. · New England Journal of Medicine | 12 Nov 1998 | 3,625 |
| 4 | Birth Prevalence of Congenital Heart Disease Worldwide Denise van der Linde, Elisabeth E.M. Konings, M. A. Slager et al. · Journal of the American College of Cardiology | Nov 2011 | 3,541 |
| 5 | The Banff 97 working classification of renal allograft pathology Lorraine C. Racusen et al. · Kidney International | Feb 1999 | 3,059 |
| 6 | Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease Michael H. Criqui, Robert D. Langer, Arnost S. Fronek et al. · New England Journal of Medicine | 6 Feb 1992 | 2,601 |
| 7 | The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth Alexander Kutikov, Robert G. Uzzo · The Journal of Urology | 18 Jul 2009 | 2,426 |
| 8 | A Controlled Trial of Renal Denervation for Resistant Hypertension Deepak L. Bhatt, David E. Kandzari, William W. O’Neill et al. · New England Journal of Medicine | 29 Mar 2014 | 2,192 |
| 9 | Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Henry Krum, Markus Peter Schlaich, Rob Whitbourn et al. · The Lancet | 30 Mar 2009 | 2,118 |
| 10 | A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention Roxana Mehran, Eve D. Aymong, Eugenia Nikolsky et al. · Journal of the American College of Cardiology | Oct 2004 | 2,049 |
| 11 | The Natural History of Chronic Allograft Nephropathy Brian J. Nankivell, Richard Borrows, Caroline L-S. Fung et al. · New England Journal of Medicine | 11 Dec 2003 | 1,953 |
| 12 | Non-Transgenic Mouse Models of Kidney Disease Michael Rabe, Franz S. Schaefer · The Nephron journals/Nephron journals | 2016 | 1,927 |
| 13 | Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States Elizabeth Selvin, Thomas P. Erlinger · Circulation | 20 Jul 2004 | 1,904 |
| 14 | Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Jorge Luiz Gross, Mirela Jobim de Azevedo, Sandra Pinho Silveiro et al. · Diabetes Care | 2005 | 1,863 |
| 15 | Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions Kim Solez et al. · American Journal of Transplantation | 19 Feb 2008 | 1,860 |
| 16 | Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996 Sundaram Hariharan, Christopher Paul Johnson, Barbara A. Bresnahan et al. · New England Journal of Medicine | 2 Mar 2000 | 1,851 |
| 17 | Transluminal Treatment of Arteriosclerotic Obstruction Charles T. Dotter, Melvin P. Judkins · Circulation | Nov 1964 | 1,772 |
| 18 | MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS G C Viberti, R. John Jarrett, U. Mahmud et al. · The Lancet | Jun 1982 | 1,680 |
| 19 | Blood Pressure and End-Stage Renal Disease in Men Michael J. Klag, Paul Kieran Whelton, Bryan L. Randall et al. · New England Journal of Medicine | 4 Jan 1996 | 1,668 |
| 20 | Takayasu Arteritis Gail S. Kerr, Claire W. Hallahan, Joseph M. Giordano et al. · Annals of Internal Medicine | Jun 1994 | 1,642 |
| 21 | ESC Guidelines on the diagnosis and treatment of peripheral artery diseases Authors/Task Force Members et al. · European Heart Journal | 26 Aug 2011 | 1,522 |
| 22 | VEGF Inhibition and Renal Thrombotic Microangiopathy Vera Eremina, J. Ashley Jefferson, Jolanta Kowalewska et al. · New England Journal of Medicine | 12 Mar 2008 | 1,514 |
| 23 | EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria Seza Özen et al. · Annals of the Rheumatic Diseases | 22 Apr 2010 | 1,459 |
| 24 | Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial Johannes F.E. Mann, Hertzel C. Gerstein, Janice Pogue et al. · Annals of Internal Medicine | 17 Apr 2001 | 1,382 |
| 25 | Body Mass Index and Risk for End-Stage Renal Disease Chi‐yuan Hsu, Charles E. McCulloch, Carlos Iribarren et al. · Annals of Internal Medicine | 3 Jan 2006 | 1,365 |
| 26 | Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis Peige Song, Diana Rudan, Yajie Zhu et al. · The Lancet Global Health | 11 Jul 2019 | 1,342 |
| 27 | A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary interventionDevelopment and initial validation Roxana Mehran, Eve A. Aymong, Eugenia Nikolsky et al. · Journal of the American College of Cardiology | 6 Oct 2004 | 1,274 |
| 28 | Revascularization versus Medical Therapy for Renal-Artery Stenosis The ASTRAL Investigators · New England Journal of Medicine | 11 Nov 2009 | 1,193 |
| 29 | A study of the quality of life and cost-utility of renal transplantation Andreas Laupacis, Paul A. Keown, Nancy Pus et al. · Kidney International | Jun 1996 | 1,183 |
| 30 | Lacunar strokes and infarcts Christopher Fisher · Neurology | Aug 1982 | 1,179 |
| 31 | Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study Carmine Zoccali, Stefanie M. Bode‐Böger, Francesca Mallamaci et al. · The Lancet | Dec 2001 | 1,097 |
| 32 | Renal-Artery Stenosis Robert D. Safian, Stephen C. Textor · New England Journal of Medicine | 8 Feb 2001 | 1,070 |
| 33 | Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement Eric L. Knight, Jacobien C. Verhave, Donna L. Spiegelman et al. · Kidney International | 11 Mar 2004 | 1,052 |
| 34 | Long-Term Consequences of Kidney Donation Hassan N. Ibrahim, Robert N. Foley, Liping Tan et al. · New England Journal of Medicine | 28 Jan 2009 | 1,052 |
| 35 | Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill · Kidney International | Apr 2009 | 1,042 |
| 36 | Rivaroxaban in Peripheral Artery Disease after Revascularization Marc P. Bonaca et al. · New England Journal of Medicine | 28 Mar 2020 | 1,028 |
| 37 | Stenting and Medical Therapy for Atherosclerotic Renal-Artery Stenosis Christopher J. Cooper, Timothy P. Murphy, Donald E. Cutlip et al. · New England Journal of Medicine | 18 Nov 2013 | 1,022 |
| 38 | DELAYED GRAFT FUNCTION: RISK FACTORS AND IMPLICATIONS FOR RENAL ALLOGRAFT SURVIVAL1 AKINLOLU O. OJO, Robert A. Wolfe, Philip J. Held et al. · Transplantation | Apr 1997 | 999 |
| 39 | New Technology and Health Care Costs — The Case of Robot-Assisted Surgery Gabriel I. Barbash, Sherry Glied · New England Journal of Medicine | 18 Aug 2010 | 997 |
| 40 | Cystatin C versus Creatinine in Determining Risk Based on Kidney Function Michael G. Shlipak, Kunihiro Matsushita, Johan Ärnlöv et al. · New England Journal of Medicine | 4 Sep 2013 | 993 |
| 41 | Risk of End-Stage Renal Disease Following Live Kidney Donation Abimereki D. Muzaale, Allan B. Massie, Mei‐Cheng Wang et al. · JAMA | 11 Feb 2014 | 989 |
| 42 | Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving et al. · Kidney International | 19 May 2004 | 978 |
| 43 | Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal Kenneth E. Lamb, Sundus A. Lodhi, H.-U. Meier-Kriesche · American Journal of Transplantation | 25 Oct 2010 | 929 |
| 44 | Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study Barry D. Kahan · The Lancet | Jul 2000 | 918 |
| 45 | The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis Brigit C. van Jaarsveld, Pieta Krijnen, H. Pieterman et al. · New England Journal of Medicine | 6 Apr 2000 | 902 |
| 46 | The Causes and Risk of Stroke in Patients with Asymptomatic Internal-Carotid-Artery Stenosis Domenico Inzitari, Michael Eliasziw, Peter Gates et al. · New England Journal of Medicine | 8 Jun 2000 | 883 |
| 47 | Survival in Recipients of Marginal Cadaveric Donor Kidneys Compared with Other Recipients and Wait-Listed Transplant Candidates AKINLOLU O. OJO, Julie A. Hanson, Herwig‐Ulf Meier‐Kriesche et al. · Journal of the American Society of Nephrology | Mar 2001 | 882 |
| 48 | Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler US. Jonathan M. Rubin, Ronald O. Bude, Paul L. Carson et al. · Radiology | Mar 1994 | 876 |
| 49 | Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection Duska Dragun, Dominik N. Müller, Jan Hinrich Bräsen et al. · New England Journal of Medicine | 9 Feb 2005 | 872 |
| 50 | The global burden of chronic kidney disease Paul Cockwell, Lori-Ann M. Fisher · The Lancet | Feb 2020 | 869 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.